| è´§å· | å“牌 | 产å“åç§° | è§„æ ¼ | 包装ã€å‚è€ƒä»·æ ¼ | |
| N797781 | MACKLIN | Naproxen Sodium | 10mM in DMSO | 237元/1ml; | 咨询 |
|
| N864223 | MACKLIN | Naproxen Sodium | 98% | 32元/1g; 54元/5g; 145元/25g; 300元/100g; 1060元/500g; | 咨询 |
储å˜ï¼š2-8°C 状æ€ï¼šç™½è‰²åˆ°ç°ç™½è‰²å›ºä½“ |
| M3406 | TCI | Naproxen Sodium | >98.0%(T)(HPLC) | 140元/5G; 290元/25G; | 咨询 |
åŸºæœ¬ä¿¡æ¯ | 纯度/åˆ†æžæ–¹æ³• | >98.0%(T)(HPLC) | | 分åå¼/分åé‡ | C14H13NaO3 = 252.24 | | 外观与形状(20℃) | 固体 | | Reaxys-RN | 6378035 | | MDLç¼–å· | MFCD00058507 |
æŠ€æœ¯è§„æ ¼ | Appearance | White to Light yellow powder to crystal | | Purity(HPLC) | min. 98.0 area% | | Purity(Nonaqueous Titration) | min. 98.0 % | | Specific rotation | -20.0 to -24.0 deg (C=0.5, 0.1mol/L NaOHaq.) | | NMR | confirm to structure |
物性(å‚考值) | 熔点 | 252 ℃ | | æœ€å¤§å¸æ”¶æ³¢é•¿ | 325(H2O) nm |
å®‰å…¨ä¿¡æ¯ | 图形或å±å®³æ ‡å¿— |  | | ä¿¡å·è¯ | è¦å‘Š | | å±é™©æ€§è¯´æ˜Ž | H361 : æ€€ç–‘å¯¹ç”Ÿè‚²èƒ½åŠ›æˆ–èƒŽå„¿é€ æˆä¼¤å®³ã€‚
| | 防范说明 | P501 : 将内装物/容器é€åˆ°æ‰¹å‡†çš„废物处ç†åނ处ç†ã€‚ P202 : 在阅读并明了所有安全措施å‰åˆ‡å‹¿æ¬åŠ¨ã€‚ P201 : 使用å‰å–得专用说明。 P280 : 戴防护手套/穿防护æœ/戴防护眼罩/戴防护é¢å…·ã€‚ P308 + P313 : 如接触到或有疑虑:求医/就诊。 P405 : å˜æ”¾å¤„é¡»åŠ é”。
|
相关法规 |
| PHR1165 | Supelco | Naproxen Sodium | Pharmaceutical Secondary Standard; Certified Reference Material | 1025.53元/1 G; | 咨询 |
产å“说明 一般æè¿° Naproxen sodium (NS) is a sodium salt of propionic acid derivative and demonstrates analgesic, anti-pyretic, and anti-inflammatory properties. It exhibits efficiency in being used as an indomethacin in the treatment of acute musculoskeletal disorders. It belongs to the group of nonsteroidal anti-inflammatory drugs (NSAIDS) and acts by inhibiting the activity of both the cyclooxygenase enzymes, COX-1 & COX-2 and further blocking the synthesis of certain prostaglandins. It is administered in the treatment of ankylosing spondylitis, osteoarthritis, rheumatoid disorders, acute gout, mild to moderate pain, tendonitis, bursitis, dysmenorrhea, fever, and migraine headache. Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. 应用 These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements. Naproxen sodium may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical formulations and combined dosage forms by chromatographic and spectrophotometric techniques. 生化/生ç†ä½œç”¨ çŽ¯åŠ æ°§é…¶(å‰åˆ—è…ºç´ H åˆæˆé…¶ 1 å’Œ 2)抑制剂。 分æžè¯´æ˜Ž These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available. 其他说明 Values of analytes vary lot to lot. This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 附注 To see an example of a Certificate of Analysis for this material enter LRAA7178 in the slot below. This is an example certificate only and may not be the lot that you receive. åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C14H13NaO3 | | 分åé‡ | 252.24 | | EC å· | 247-486-2 | | MDLç¼–å· | MFCD00058507 | | PubChem化å¦ç‰©è´¨ç¼–å· | 329823182 | | NACRES | NA.24 |
äº§å“æ€§è´¨ | è´¨é‡æ°´å¹³ | 300 | | ç‰çº§ | certified reference material pharmaceutical secondary standard | | CofA | current certificate can be downloaded | | technique(s) | HPLC: suitable gas chromatography (GC): suitable | | application(s) | pharmaceutical (small molecule) | | æ ¼å¼ | neat | | è¯å…¸å¯è¿½æº¯æ€§ | traceable to USP 1457403 | | å‚¨å˜æ¸©åº¦ | 2-30℃ | | SMILES string | [Na+].COc1ccc2cc(ccc2c1)[C@H](C)C([O-])=O | | InChI | 1S/C14H14O3.Na/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10;/h3-9H,1-2H3,(H,15,16);/q;+1/p-1/t9-;/m0./s1 | | InChI key | CDBRNDSHEYLDJV-FVGYRXGTSA-M | | Gene Information | human ... PTGS1(5742), PTGS2(5743) |
å®‰å…¨ä¿¡æ¯ | 象形图 |   | | è¦ç¤ºç”¨è¯ï¼š | Danger | | å±é™©å£°æ˜Ž | H302 - H360 | | 预防措施声明 | P201 - P202 - P264 - P270 - P301 + P312 - P308 + P313 | | å±é™©åˆ†ç±» | Acute Tox. 4 Oral - Repr. 1A | | 储å˜åˆ†ç±»ä»£ç | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| M1275 | Sigma-Aldrich | Naproxen Sodium | 98.0-102.0% | 1086.96元/5 G; 2532.84元/25 G; 4348.62元/50 G; | 咨询 |
产å“说明 一般æè¿° è˜æ™®ç”Ÿå±žäºŽè‹¯ä¹™é…¸ç±»éžç”¾ä½“æŠ—ç‚Žè¯ (NSAID)。 应用 è˜æ™®ç”Ÿé’ 已被用于评价牛血清白蛋白和人血清白蛋白生物分å相互作用的çƒåŠ›å¦ã€‚其也被用于评价其é™ä½Žè„Šé«“背角神ç»å…ƒå¯¹ä¼¤å®³æ€§è†å…³èŠ‚æ—‹è½¬å应的效率。 包装 5, 25, 50 g in poly bottle 生化/生ç†ä½œç”¨ è˜æ™®ç”Ÿæœ€å¥½ä¸Žè¡€æ¸…白蛋白结åˆã€‚与 R-å¼‚æž„ä½“ç›¸æ¯”ï¼Œè˜æ™®ç”Ÿçš„ S-异构体作为抗炎è¯ç‰©çš„æ½œåŠ›æ˜¯å‰è€…çš„ 28 å€ã€‚å‘现 R-异构体是一ç§è‚è„æ¯’ç´ ï¼Œå¯å¯¼è‡´èƒƒè‚ é“疾病。 çŽ¯åŠ æ°§é…¶(å‰åˆ—è…ºç´ H åˆæˆé…¶ 1 å’Œ 2)抑制剂。 特点和优势 该化åˆç‰©ç”±Bayerå¼€å‘ã€‚è¦æµè§ˆå…¶ä»–è¯ç‰©å¼€å‘化åˆç‰©å’Œæ‰¹å‡†çš„è¯ç‰©/候选è¯ç‰©åˆ—表,å•击æ¤å¤„。 åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C14H13NaO3 | | 分åé‡ | 252.24 | | EC å· | 247-486-2 | | MDLç¼–å· | MFCD00058507 | | PubChem化å¦ç‰©è´¨ç¼–å· | 57654352 | | NACRES | NA.77 |
äº§å“æ€§è´¨ | è´¨é‡æ°´å¹³ | 200 | | ç”Ÿç‰©æ¥æº | synthetic (organic) | | 测定 | 98.0-102.0% | | å½¢å¼ | powder | | 溶解性 | water: 100 mg/mL, clear to slightly hazy, colorless to faintly yellow | | 创始人 | Bayer | | SMILES string | [Na+].COc1ccc2cc(ccc2c1)[C@H](C)C([O-])=O | | InChI | 1S/C14H14O3.Na/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10;/h3-9H,1-2H3,(H,15,16);/q;+1/p-1/t9-;/m0./s1 | | InChI key | CDBRNDSHEYLDJV-FVGYRXGTSA-M | | Gene Information | human ... PTGS1(5742), PTGS2(5743) |
å®‰å…¨ä¿¡æ¯ | 象形图 |   | | è¦ç¤ºç”¨è¯ï¼š | Danger | | å±é™©å£°æ˜Ž | H302 - H360 | | 预防措施声明 | P201 - P301 + P312 + P330 - P308 + P313 | | å±é™©åˆ†ç±» | Acute Tox. 4 Oral - Repr. 1A | | 储å˜åˆ†ç±»ä»£ç | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 个人防护装备 | dust mask type N95 (US), Eyeshields, Gloves |
|
| N5160 | Sigma-Aldrich | Naproxen Sodium | meets USP testing specifications | 824.69元/5 G; 5455.55元/50 G; | 咨询 |
产å“说明 包装 5, 50 g in poly bottle 生化/生ç†ä½œç”¨ çŽ¯åŠ æ°§é…¶(å‰åˆ—è…ºç´ H åˆæˆé…¶ 1 å’Œ 2)抑制剂。 åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C14H13NaO3 | | 分åé‡ | 252.24 | | EC å· | 247-486-2 | | MDLç¼–å· | MFCD00058507 | | PubChem化å¦ç‰©è´¨ç¼–å· | 24897724 | | NACRES | NA.21 |
äº§å“æ€§è´¨ | è´¨é‡æ°´å¹³ | 100 | | agency | USP/NF meets USP testing specifications | | å½¢å¼ | powder | | application(s) | pharmaceutical (small molecule) | | SMILES string | [Na+].COc1ccc2cc(ccc2c1)[C@H](C)C([O-])=O | | InChI | 1S/C14H14O3.Na/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10;/h3-9H,1-2H3,(H,15,16);/q;+1/p-1/t9-;/m0./s1 | | InChI key | CDBRNDSHEYLDJV-FVGYRXGTSA-M | | Gene Information | human ... PTGS1(5742), PTGS2(5743) |
å®‰å…¨ä¿¡æ¯ | 象形图 |   | | è¦ç¤ºç”¨è¯ï¼š | Danger | | å±é™©å£°æ˜Ž | H302 - H360 | | 预防措施声明 | P201 - P301 + P312 + P330 - P308 + P313 | | å±é™©åˆ†ç±» | Acute Tox. 4 Oral - Repr. 1A | | 储å˜åˆ†ç±»ä»£ç | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | dust mask type N95 (US), Eyeshields, Gloves |
|
| 1457403 | USP | Naproxen Sodium | United States Pharmacopeia (USP) Reference Standard | 3231.47元/200 MG; | 咨询 |
产å“说明 一般æè¿° This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生ç†ä½œç”¨ çŽ¯åŠ æ°§é…¶(å‰åˆ—è…ºç´ H åˆæˆé…¶ 1 å’Œ 2)抑制剂。 分æžè¯´æ˜Ž These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C14H13NaO3 | | 分åé‡ | 252.24 | | MDLç¼–å· | MFCD00058507 | | PubChem化å¦ç‰©è´¨ç¼–å· | 329750531 | | NACRES | NA.24 |
äº§å“æ€§è´¨ | ç‰çº§ | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | æ ¼å¼ | neat | | SMILES string | [Na+].COc1ccc2cc(ccc2c1)[C@H](C)C([O-])=O | | InChI | 1S/C14H14O3.Na/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10;/h3-9H,1-2H3,(H,15,16);/q;+1/p-1/t9-;/m0./s1 | | InChI key | CDBRNDSHEYLDJV-FVGYRXGTSA-M | | Gene Information | human ... PTGS1(5742), PTGS2(5743) |
å®‰å…¨ä¿¡æ¯ | 象形图 |   | | è¦ç¤ºç”¨è¯ï¼š | Danger | | å±é™©å£°æ˜Ž | H302 - H360 | | 预防措施声明 | P201 - P280 - P301 + P312 + P330 - P308 + P313 | | å±é™©åˆ†ç±» | Acute Tox. 4 Oral - Repr. 1A | | 储å˜åˆ†ç±»ä»£ç | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 546548 | Fluorochem | Sodium (S)-2-(6-Methoxynaphthalen-2-yl)propanoate | 98+% | 638元/1g; 968元/5g; 3322元/25g; | 咨询 |
åŸºæœ¬ä¿¡æ¯ | CAS Number | 26159-34-2 | | MDL Number | MFCD00058507 |
å®‰å…¨ä¿¡æ¯ | 图形或å±å®³æ ‡å¿— |  | | å±é™©æ€§è¯´æ˜Ž | H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation.
| | 防范说明 | P233: Keep container tightly closed. P260: Do not breathe . P261: Avoid breathing . P264: Wash hands thoroughly after handling. P271: Use only outdoors or in a well-ventilated area. P280: Wear . P302 + P352: IF ON SKIN: Wash with plenty of soap and water. P304: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.. P304 + P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P312: Call a POISON CENTER or doctor/physician if you feel unwell. P321: Specific treatment (see relevant procedures. on this label). P332 + P313: If skin irritation occurs: Get medical advice/ attention. P337 + P313: If eye irritation persists: Get medical advice/attention. P340: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P362: Take off contaminated clothing and wash before reuse. P403: Store in a well-ventilated place. P403 + P233: Store in a well-ventilated place. Keep container tightly closed. P405: Store locked up. P501: Dispose of contents/container to in accordance with local regulation .
|
|